Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for mothers with chorioamnionitis and/or their infants
IRCT20251017067663N1Phase 2Recruiting
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of acetylcysteine in intraamniotic infection (IAI) (4 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Changes in oxidant-antioxidant balance after intervention. Started Jul 2026; status: recruiting.
02
Drugs
acetylcysteine
03
Conditions
intraamniotic infection (IAI)
Beyond the preview
Go deeper on IRCT20251017067663N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251017067663N1.